|
|
Volumn 105, Issue 2, 2008, Pages 125-142
|
|
Monitoring of AMD patients on Anti-Vascular Endothelial Growth Factor (VEGF) Treatment : Practial notes on functional and anatomical examination parameters from Drug approval studies, specialist information and case series;Monitoring von AMD-Patienten unter Anti-VEGF-Therapie : Praktische Hinweise zu funktionellen und anatomischen Untersuchungsparametern aus Zulassungsstudien, Fachinformationen und Fallserien
a
|
|
Author keywords
Age related macular degeneration (AMD); Anti VEGF treatment; Exudative AMD; Loss of eyesight; Optical coherence tomography (OCT)
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
APTAMER;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
PEGAPTANIB;
PHOTOSENSITIZING AGENT;
PORPHYRIN;
RANIBIZUMAB;
VASCULOTROPIN A;
VERTEPORFIN;
AGED;
ARTICLE;
BLINDNESS;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INJECTION;
META ANALYSIS;
MONITORING;
MULTICENTER STUDY;
OPTICAL COHERENCE TOMOGRAPHY;
PHASE 3 CLINICAL TRIAL;
PHOTOCHEMOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
RETINA MACULA DEGENERATION;
RETROSPECTIVE STUDY;
SUBRETINAL NEOVASCULARIZATION;
TIME;
TREATMENT OUTCOME;
VISION TEST;
VISUAL ACUITY;
VITREOUS BODY;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
APTAMERS, NUCLEOTIDE;
BLINDNESS;
CHOROIDAL NEOVASCULARIZATION;
CLINICAL TRIALS, PHASE III AS TOPIC;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS;
MACULAR DEGENERATION;
META-ANALYSIS AS TOPIC;
MONITORING, PHYSIOLOGIC;
MULTICENTER STUDIES AS TOPIC;
PHOTOCHEMOTHERAPY;
PHOTOSENSITIZING AGENTS;
PORPHYRINS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISION TESTS;
VISUAL ACUITY;
VITREOUS BODY;
|
|
EID: 40249094403
PISSN: 0941293X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00347-008-1702-6 Document Type: Article |
|
Times cited : (17)
|
|
References (69)
|
